 |
인쇄하기
취소
|
Standards for new drug examination data more to define.
The KFDA plans to refine the scope of the examination data more precisely for drug or new drug reviews, and to reinforce the administrative punishment.
The current provisions required the drug efficacy data for drugs or new drug reviews by diseases or patients, the drug adverse reaction data as available in domestic as well as overseas sources, the free sales certificates or product registr...
The current provisions required the drug efficacy data for drugs or new drug reviews by diseases or patients, the drug adverse reaction data as available in domestic as well as overseas sources, the free sales certificates or product registr...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.